Accuracy of the Brief Cognitive Screening Battery for diagnosing Alzheimer's disease defined by cerebrospinal fluid biomarkers and AT(N) classification: a case-control study

por Peles, Patrícia Regina Henrique, Salvador, Larissa de Souza, de Souza, Leonardo Cruz, Caramelli, Paulo
Publicado 2021

Good rate of clinical response to cholinesterase inhibitors in mild and moderate Alzheimer's disease after three months of treatment: An open-label study

por de Miranda, Luis Felipe José Ravic, Barbosa, Marilourdes do Amaral, Peles, Patrícia Regina Henrique, Pôças, Patrícia Hilar, Tito, Pedro Augusto Lopes, Matoso, Rafael de Oliveira, de Lima, Thiago Oliveira Lemos, de Moraes, Edgar Nunes, Caramelli, Paulo
Publicado 2013